CTTH insider trades & Congress trades
Ctt Pharmaceutical Holdings, Inc.: public insider filings and Congress disclosures, in one place.
Bourse has recorded 15 open-market insider transactions in Ctt Pharmaceutical Holdings, Inc. (CTTH) (15 purchases with code P and 0 sales with code S), the most recent on October 26, 2026.
In the last 90 days: 14 purchases by 1 insider ($4K) and 0 sales by 0 ($0).
Insider transactions
SEC Form 4, open-market purchases (P) and sales (S) only. Awards, option exercises and tax withholding are excluded. “After” shows the stock’s return over the month following the trade, where available.
| Date | Insider | Role | Type | Shares | Price | Value | After 1M |
|---|---|---|---|---|---|---|---|
| Oct 26, 2026 | Ctt Pharmaceutical Holdings, Inc. | CEO | Buy | 5,880 | $0.06 | $335 | – |
| Oct 15, 2026 | Ctt Pharmaceutical Holdings, Inc. | CEO | Buy | 2,000 | $0.06 | $114 | – |
| Oct 6, 2026 | Ctt Pharmaceutical Holdings, Inc. | CEO | Buy | 3,700 | $0.06 | $204 | – |
| Sep 28, 2026 | Ctt Pharmaceutical Holdings, Inc. | CEO | Buy | 3,400 | $0.06 | $187 | – |
| Sep 22, 2026 | Ctt Pharmaceutical Holdings, Inc. | CEO | Buy | 10,100 | $0.05 | $455 | – |
| Sep 16, 2026 | Ctt Pharmaceutical Holdings, Inc. | CEO | Buy | 10,900 | $0.05 | $523 | – |
| Sep 10, 2026 | Ctt Pharmaceutical Holdings, Inc. | CEO | Buy | 3,500 | $0.05 | $175 | – |
| Sep 4, 2026 | Ctt Pharmaceutical Holdings, Inc. | CEO | Buy | 9,800 | $0.05 | $479 | – |
| Sep 2, 2026 | Ctt Pharmaceutical Holdings, Inc. | CEO | Buy | 3,000 | $0.05 | $147 | – |
| Aug 31, 2026 | Ctt Pharmaceutical Holdings, Inc. | CEO | Buy | 3,500 | $0.05 | $172 | +0.2% |
| Aug 24, 2026 | Ctt Pharmaceutical Holdings, Inc. | CEO | Buy | 2,100 | $0.06 | $116 | −0.1% |
| Aug 20, 2026 | Ctt Pharmaceutical Holdings, Inc. | CEO | Buy | 11,500 | $0.05 | $518 | −0.2% |
| Aug 19, 2026 | Ctt Pharmaceutical Holdings, Inc. | CEO | Buy | 10,000 | $0.06 | $590 | −0.1% |
| Aug 14, 2026 | Ctt Pharmaceutical Holdings, Inc. | CEO | Buy | 1,800 | $0.06 | $112 | −0.2% |
| Aug 7, 2026 | Ctt Pharmaceutical Holdings, Inc. | CEO | Buy | 7,700 | $0.07 | $501 | −0.1% |
Data as of November 8, 2026. Public filings only. A purchase or sale by a politician or an insider does not by itself imply any wrongdoing.
New to these filings? Read how to read a Form 4, how Congress trades are disclosed and what insider cluster buying means. Sources and limits are on the Methodology page.
See these filings as they land
Bourse collects Congress trades, SEC Form 4 insider filings and 13F fund holdings in one live feed, and flags insider buying clusters automatically. Free to start.
Bourse provides financial data and editorial information, parts of which are generated by AI. This page is for general education only. It is not personalised investment advice or a recommendation to buy or sell any financial instrument. Make your own decisions.